Success Metrics

Clinical Success Rate

50.0%

Based on 1 completed trials

Completion Rate

50%(1/2)

Active Trials

1(33%)

Results Posted

0%(0 trials)

Terminated

1(33%)

Phase Distribution

Ph phase_1

33%

Ph not_applicable

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 1Safety & dosage

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Terminated(1)

Detailed Status

Completed1

Terminated1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (50.0%)

N/A1 (50.0%)

Trials by Status

completed133%

terminated133%

active_not_recruiting133%

Recent Activity

1 active trials

Showing 3 of 3

terminated

SEBBIN INTEGRITY Round Implants

NCT05642390

active_not_recruitingnot_applicable

Breast Reconstruction With External Pre-expansion and Autologous Fat Transfer Versus Standard Therapy

NCT02339779

completedphase_1

Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy

NCT03213249

Clinical Trials (3)

Showing 3 of 3 trials

NCT05642390

SEBBIN INTEGRITY Round Implants

Terminated

NCT02339779Not Applicable

Breast Reconstruction With External Pre-expansion and Autologous Fat Transfer Versus Standard Therapy

Active Not Recruiting

NCT03213249Phase 1

Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy

Completed

All 3 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 3